Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)

Registry ID

EUCTR2014-003605-15

Source registry

EUCTR

Phase

PHASE3

Sponsor

CSL Behring AG

Last update

2026-08-16

Conditions

• Primary Immune Deficiency (PID)

Summary

The purpose of this study is to determine whether a long-term use of a new human immunoglobulin G with proline (IgPro) is safe and effective in the treatment of primary immunodeficiency.

Related clinical trials

• Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies

View on source registry